NASDAQ: BRVE
Braveheart Bio Inc Earnings Dates, Reports, Calls

Braveheart Bio earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BRVE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$14.3M, down N/A from last quarter.

BRVE earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

BRVE Return on Equity

Insufficient data to display

BRVE Return on Assets

Insufficient data to display

Be the first to know when BRVE announces earnings.

BRVE Return on Capital Employed

Current Company
0%
Current Industry
-9.6%

BRVE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABVC-$7.88M-$8.63MN/A-$0.39
ABVX-$249.95M-$390.82MN/A-$5.28
ACET-$89.96M-$98.97MN/A-$10.46
ACXP-$7.50M-$7.50MN/A-$4.05
AARD-$69.47M-$69.87MN/A-$3.21

Braveheart Bio Earnings Reports & History FAQ

What were Braveheart Bio's earnings last quarter?

Braveheart Bio (NASDAQ: BRVE) reported Q1 2026 earnings per share (EPS) of -$2.08, up Infinity% year over year. Total BRVE earnings for the quarter were -$14.28 million. In the same quarter last year, Braveheart Bio's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Braveheart Bio stock.

Is Braveheart Bio profitable or losing money?

As of the last Braveheart Bio earnings report, Braveheart Bio is currently losing money. Braveheart Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was BRVE's earnings growth in the past year?

As of Braveheart Bio's earnings date in Q3 2026, Braveheart Bio's earnings has grown year over year. BRVE earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.